For patients with melanoma (15–17), gastric (18, 19) and liver cancer (20), gynecological (21, 22) and breast cancer (23, 24), and renal clear cell carcinoma (25), higher ICOS expression predicted much worse survival. The gene discussed is ICOS; the disease is breast cancer.